-
1
-
-
85022564931
-
-
(Merck) U. S. Pat. 5 132 216
-
Chen, S. T.; Dost, G. (Merck) U. S. Pat. 5 132 216, 1992.
-
(1992)
-
-
Chen, S.T.1
Dost, G.2
-
2
-
-
85022541616
-
-
(ICI). Eur. Pat. 399 731
-
Roberts, D. A.; Russel, S. T.; Ratcliffe, A. H.; Gibson, K. H.; Wood, R. (ICI). Eur. Pat. 399 731, 1990.
-
(1990)
-
-
Roberts, D.A.1
Russel, S.T.2
Ratcliffe, A.H.3
Gibson, K.H.4
Wood, R.5
-
4
-
-
85022562008
-
-
(Searle) U. S. Pat. 5 359 073
-
Weier, R. M.; Khanna, I. K.; Lentz, K.; Stealey, M. A.; Julien, J. (Searle) U. S. Pat. 5 359 073, 1994.
-
(1994)
-
-
Weier, R.M.1
Khanna, I.K.2
Lentz, K.3
Stealey, M.A.4
Julien, J.5
-
5
-
-
0346351334
-
-
Temple, C., Jr.; Rose, J. D.; Comber, R. N.; Rener, G. A. J. Med. Chem. 1987, 30, 1746.
-
(1987)
J. Med. Chem.
, vol.30
, pp. 1746
-
-
Temple, C.1
Rose, J.D.2
Comber, R.N.3
Rener, G.A.4
-
6
-
-
0015593485
-
-
Temple, C., Jr.; Smith, B. H.; Elliott, R. D.; Montgomery, J. A. J. Med. Chem. 1973, 16, 292.
-
(1973)
J. Med. Chem.
, vol.16
, pp. 292
-
-
Temple, C.1
Smith, B.H.2
Elliott, R.D.3
Montgomery, J.A.4
-
7
-
-
0025289433
-
-
Barraclough, P.; Black, J. W.; Cambridge, D.; Collard, D.; Firmin, D.; Gerskowitch, V. P.; Glen, R. C.; Giles, H.; Hill, A. P.; Hull, R. A. D.; Iyer, R.; King, W. R.; Kneen, C. O.; Lindon, J. C.; Nobbs, M. S.; Randall, P.; Shah, G. P.; Smith, S.; Vine, S. J.; Whiting, M. V.; Williams, J. M. J. Med. Chem. 1990, 33, 2231.
-
(1990)
J. Med. Chem.
, vol.33
, pp. 2231
-
-
Barraclough, P.1
Black, J.W.2
Cambridge, D.3
Collard, D.4
Firmin, D.5
Gerskowitch, V.P.6
Glen, R.C.7
Giles, H.8
Hill, A.P.9
Hull, R.A.D.10
Iyer, R.11
King, W.R.12
Kneen, C.O.13
Lindon, J.C.14
Nobbs, M.S.15
Randall, P.16
Shah, G.P.17
Smith, S.18
Vine, S.J.19
Whiting, M.V.20
Williams, J.M.21
more..
-
8
-
-
0025003618
-
-
Barraclough, P.; Beams, R. M.; Black, J. W.; Cambridge, D.; Collard, D.; Demaine, D. A.; Firmin, D.; Gerskowitch, V. P.; Glen, R. C.; Giles, H.; Hill, A. P.; Hull, R. A. D.; Iyer, R.; King, W. R.; Livingstone, D. J.; Nobbs, M. S.; Randall, P., Shah, G. P.; Vine, S. J.; Whiting, M. V. Eur. J. Med. Chem. 1990, 25, 467.
-
(1990)
Eur. J. Med. Chem.
, vol.25
, pp. 467
-
-
Barraclough, P.1
Beams, R.M.2
Black, J.W.3
Cambridge, D.4
Collard, D.5
Demaine, D.A.6
Firmin, D.7
Gerskowitch, V.P.8
Glen, R.C.9
Giles, H.10
Hill, A.P.11
Hull, R.A.D.12
Iyer, R.13
King, W.R.14
Livingstone, D.J.15
Nobbs, M.S.16
Randall, P.17
Shah, G.P.18
Vine, S.J.19
Whiting, M.V.20
more..
-
9
-
-
0022361384
-
-
Janssens, F.; Torremans, J.; Janssen, M.; Stokbroekx, R. A.; Luyckx, M.; Janssen, P. A. J. J. Med. Chem. 1985, 28, 1943.
-
(1985)
J. Med. Chem.
, vol.28
, pp. 1943
-
-
Janssens, F.1
Torremans, J.2
Janssen, M.3
Stokbroekx, R.A.4
Luyckx, M.5
Janssen, P.A.J.6
-
10
-
-
85022523609
-
-
Of the regioselective syntheses of AT-alkylated imidazo[4, 5-6]-pyridines and 2, 3-diaminopyridines reported in literature, the preparation of 2- (alkylamino)-3-aminopyridines seems the simplest as these can be easily prepared by starting with 2-chloro-3-nitropyridines (Ciba-Geigy); U. S. Pat. 3 719 683 see also ref 5
-
Of the regioselective syntheses of AT-alkylated imidazo[4, 5-6]-pyridines and 2, 3-diaminopyridines reported in literature, the preparation of 2- (alkylamino)-3-aminopyridines seems the simplest as these can be easily prepared by starting with 2-chloro-3-nitropyridines. Robison, M. M.; Switzerland, R.; Finch, N. (Ciba-Geigy); U. S. Pat. 3 719 683, 1973; see also ref 5.
-
(1973)
-
-
Robison, M.M.1
Switzerland, R.2
Finch, N.3
-
11
-
-
85022565764
-
-
(Laboratoires U. P. S. A.); French Pat. 8363
-
Faure, A. (Laboratoires U. P. S. A.); French Pat. 8363, 1971.
-
(1971)
-
-
Faure, A.1
-
13
-
-
37049124788
-
-
For pKa studies on 2, 3-diaminopyridines, see (a)
-
For pKa studies on 2, 3-diaminopyridines, see (a) Bellobono, I. R.; Favini, G. J. Chem. Soc. (B) 1971, 2034.
-
(1971)
J. Chem. Soc. (B)
, pp. 2034
-
-
Bellobono, I.R.1
Favini, G.2
-
15
-
-
24044512963
-
-
Substituted benzaldehydes 10 and 16, the intermediates used in our PAF program, were initially prepared from the corresponding benzyl bromides by direct oxidation using trimethylamine N-oxide in DMSO. However, this transformation could not be scaled up very well and we routinely preferred to use the three-step sequence involving (a) displacement of the substituted benzyl bromide with acetate (NaOAc, DMF) (b) hydrolysis (aqueous K2CO3) of the ester, and (c) oxidation (PCC) to the desired aldehyde. The synthesis of substituted benzyl bromides has been reported (Searle). U. S. Patent 4 914 108 and 5 019 581
-
Substituted benzaldehydes 10 and 16, the intermediates used in our PAF program, were initially prepared from the corresponding benzyl bromides by direct oxidation using trimethylamine N-oxide in DMSO. However, this transformation could not be scaled up very well and we routinely preferred to use the three-step sequence involving (a) displacement of the substituted benzyl bromide with acetate (NaOAc, DMF) (b) hydrolysis (aqueous K2CO3) of the ester, and (c) oxidation (PCC) to the desired aldehyde. The synthesis of substituted benzyl bromides has been reported: Khanna, I. K.; Nosal, R.; Weier, R. M. (Searle). U. S. Patent 4 914 108 and 5 019 581; Chem. Abstr. 1990, 112, 235299z.
-
(1990)
Chem. Abstr.
, vol.112
, pp. 235299z
-
-
Khanna, I.K.1
Nosal, R.2
Weier, R.M.3
-
16
-
-
37049065442
-
-
For formation of ¡mines using molecular sieves, see (a)
-
For formation of ¡mines using molecular sieves, see (a) Bonnett, R.; Emerson, T. R. J. Chem. Soc. 1965, 4508.
-
(1965)
J. Chem. Soc.
, pp. 4508
-
-
Bonnett, R.1
Emerson, T.R.2
|